SARS-CoV-2 Mpro-IN-39
SARS-CoV-2 Mpro-IN-39 (Compound 9d) is an inhibitor of the main protease (Mpro) of SARS-CoV-2, with an IC50 value of 5.94 µM, an EC50 value of 9.33 µM for inhibiting the replication of SARS-CoV-2 in Vero cells, and a cytotoxicity CC50 value of 289.63 µM. SARS-CoV-2 Mpro-IN-39 can be used in the research of the anti-COVID-19 field[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
CC1=C(/C=C/C2=CC=CC=C2[N+]([O-])=O)SC(N/N=C3CCCCC4=C\3C=CC=C4)=N1
Molecular Formula
C23H22N4O2S
Molecular Weight
418.51
References & Citations
[1]Farghaly TA, et al. Novel Benzosuberone/Indanone-Linked Thiazoles as Small-Molecule SARS-CoV-2 Main Protease Inhibitors. Drug Dev Res. 2025 Apr;86 (2) :e70081.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP303942M 100 µg
NCE2 (UBE2F) (NM_080678) Human Recombinant Protein
Sign In for Pricing
View Details 